Cancer patients may experience delayed skin effects of anti-PD-1 therapy

(University of Pennsylvania School of Medicine) Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay -- sometimes even after treatment has concluded.

Source: EurekAlert! - Cancer - July 18, 2018 Category: Cancer & Oncology Source Type: news